Zimbabwe has declined a major American healthcare agreement valued at 367 million US dollars (£272m) over five years because of Washington's request for confidential biological samples.
This move was revealed following a internal memorandum dated December was leaked, revealing that President Emmerson Mnangagwa felt the agreement was "lopsided".
An official spokesman later explained that the US was requesting biological samples for research and profit but was unwilling to guarantee the resulting advantages from future medical innovations.
"We will now turn to the challenging and unfortunate task of winding down our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the US had provided over $1.9bn as health assistance to Zimbabwe during the past two decades.
A medical body in Zimbabwe has called for continued negotiations to reach a deal suitable to all parties so the country's critical HIV programme can continue.
Wider Implications
This rejection follows a comparable situation in Kenya, where a court blocked a related health funding agreement following legal challenges were raised about the security of Kenyans' medical information.
Since resuming the presidency last year, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
USAID had managed assistance for the US government, but Trump stated its spending was "inefficient" and his administration was pursuing government-to-government deals to boost transparency and accountability.
According to reports, 16 African countries have to date agreed to these new agreements, constituting more than $18.3bn in committed funds.
Details of the Rejected Deal
The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this partnership could have provided immense advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on antiretroviral therapy through American-funded programmes," Tremont said.
However, government spokesperson Nick Mangwana argued the proposed deal was "unfair".
"Our nation was requested to surrender its biological resources and data indefinitely, without any equivalent assurance of access to any medical innovations – like vaccines, diagnostics, or treatments – that might be developed from that shared data," Mangwana explained.
"Effectively, our country would provide the basic resources for scientific discovery with no assurance that the resulting innovations would be accessible to our population should a new disease outbreak arise."
National Interest and Global Health
Mangwana further pointed out that the American exit from the global health body and its push of one-on-one health agreements were disrupting systems already established via the global organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage future pandemics.
"This mechanism is intended to guarantee that when a nation provides its information, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to develop them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We welcome further discussions with our US partners on how subsequent co-operation could be arranged in a way that respects the sovereignty and dignity of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but suggested that talks should continue since much of the nation's HIV programmes relied on external financing.
"Where technical issues arise, including those involving information security or agreement terms, these can frequently be resolved through detailed discussion and negotiated safeguards," the group commented.
The halted deal highlights the continuing challenges between receiving vital international aid and protecting a country's data in an ever more data-driven world.